AM-710 is an ultra-long-acting prodrug of orforglipron, with >150-fold half-life extension, enabling once every 3 month and once every 6 month dosing or longer A single subcutaneous dose of AM-710 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results